PubMed Health⌕ Search

Biomedical subjects

Howard Seltman

Publications and source records attributed to Howard Seltman.

6 recordsLinked to original sources

Evaluation of a susceptibility gene for schizophrenia: genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples.

BACKGROUND: Associations between schizophrenia (SCZ) and polymorphisms at the regulator of G-protein signaling 4 (RGS4) gene have been reported (single nucleotide polymorphisms [SNPs] 1, 4, 7, and 18). Yet, similar to other SCZ candidate genes, studies have been inconsistent with respect to the associated alleles. METHODS: In an effort to resolve the role for RGS4 in SCZ susceptibility, we undertook a genotype-based meta-analysis using both published and unpublished family-based and case-control samples (total n = 13,807). RESULTS: The family-based dataset consisted of 10 samples (2160 families). Significant associations with individual SNPs/haplotypes were not observed. In contrast, global analysis revealed significant transmission distortion (p = .0009). Specifically, analyses suggested overtransmission of two common haplotypes that account for the vast majority of all haplotypes. Separate analyses of 3486 cases and 3755 control samples (eight samples) detected a significant association with SNP 4 (p = .01). Individual haplotype analyses were not significant, but evaluation of test statistics from individual samples suggested significant associations. CONCLUSIONS: Our collaborative meta-analysis represents one of the largest SCZ association studies to date. No individual risk factor arose from our analyses, but interpretation of these results is not straightforward. Our analyses suggest risk due to at least two common haplotypes in the presence of heterogeneity. Similar analysis for other putative susceptibility genes is warranted.

Case-Control Studies↗

The role of care location in diagnosis and treatment of pediatric psychosocial conditions.

Racial differences in diagnosis and treatment of psychosocial conditions have been well documented. It is unclear if these differences represent variance in prevalence or are actually disparities in care driven by social factors, income-related differences, or differences in the actual location of care. We used 4 years of National Ambulatory Medical Care Surveys and National Hospital Ambulatory Medical Care Surveys as source for data on visits to private offices and hospital-based clinics. In addition to the standard practice of combining surveys across years, we used a "supersurvey" approach to combining the 2 distinct surveys. In our roughly 20,000 sampled visits, we confirmed the higher concentration of low-income children in visits to hospital-based clinics (p <.001), but saw no significant racial difference (p =.104). After controlling for race, income, and other demographics, we found that visits to hospital-based clinics were significantly more likely to include a diagnosis of depression (odds ratio [OR], 4.4; p =.011), but that there was no statistically significant difference in other psychosocial diagnoses. Once a diagnosis is made, there is no evidence of differences in treatment or follow-up between office-based or hospital clinic-based providers. Our analyses support previously gathered evidence for differences in economic status of the clientele of private offices and hospital-based clinics. We surprisingly found visits to clinics to be more likely to include a depression diagnosis, but this may be an artifact of the data reflecting visits rather than patients. We found no evidence that treatment or follow-up is different for the disadvantaged who use clinics rather than private offices.

Adolescent↗

Do antidepressants cause suicidality in children? A Bayesian meta-analysis.

BACKGROUND: To quantify the risk of suicidal behavior/ideation (suicidality) for children who use antidepressants, the FDA collected randomized placebo-controlled trials of antidepressant efficacy in children. Although none of the 4487 children completed suicide, 1.7% exhibited suicidality. The FDA meta-analyzed these studies and found sufficient evidence of an increased risk to require a black-box warning on antidepressants for children. PURPOSE: The FDA considered different drug formulations and psychiatric diagnoses to be equivalent in their effect on suicidality. If this assumption does not hold, the FDA analysis may have underestimated the variance of the risk estimate. We investigate the consequences of relaxing these assumptions. METHODS: We extend the FDA analysis using a Bayesian hierarchical model that allows for a study-level component of variability and facilitates extensive sensitivity analyses. RESULTS: We found an association between antidepressant use and an increased risk of suicidality in studies where the diagnosis was major depressive disorder (odds ratio 2.3 [1.3, 3.8]), and where the antidepressant was an SSRI (odds ratio 2.2 [1.3, 3.6]). We did not find evidence for such an association in the complement sets of trials. Although the results based on the hierarchical model are insensitive to model perturbations, the robustness of the FDA's meta-analysis to model assumptions is less clear. These data have limited generalizability due to exclusion of patients with baseline risk of suicide and the use of relatively short duration trials. CONCLUSIONS: Because of model specification and interpretation issues raised in this paper, we conclude that the evidence supporting a causal link between antidepressant use and suicidality in children is weak. The use of Bayesian hierarchical models for meta-analysis has facilitated the incorporation of potentially important sources of variability and the use of sensitivity analysis to assess the consequences of model specifications and their impact on important regulatory decisions.

Antidepressive Agents↗

Using prior distributions to synthesize historical evidence: comments on the Goodman-Sladky case study of IVIg in Guillain-Barré syndrome.

One feature of the Bayesian approach is that it provides methods for synthesizing what is known about a question of interest and provides a formalism based on the laws of probability for incorporating this auxiliary knowledge into the planning and the analysis of the next study. In this comment, we use elements of the Goodman-Sladky case study to illustrate (1) the use of Bayesian methods to quantify historical information about an intervention through the specification of a prior distribution, (2) an approach to the analysis of the sensitivity of the conclusions of a Bayesian analysis to the specification of the prior distribution, and (3) we comment on the role of research synthesis for combining information about an intervention from different data sources as a tool to help summarize evidence about the intervention.

Adult↗

Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change.

The goal of this study was to identify distinct trajectories of adjustment to breast cancer over 4 years as well as to distinguish among the different trajectories. The mental and physical functioning of 287 women with breast cancer who remained alive and disease free through 4 years of follow-up were examined. The majority of women showed slight and steady improvement in functioning with time, but subgroups of women were identified who showed marked improvement and marked deteriorations over time. Age successfully distinguished different trajectories of physical functioning. Indices of personal resources (i.e., self-image, optimism, perceived control) and social resources (i.e., social support) successfully distinguished different courses of mental and physical functioning.

Adaptation, Physiological↗

Evolutionary-based association analysis using haplotype data.

Association studies, both family-based and population-based, can be powerful means of detecting disease-liability alleles. To increase the information of the test, various researchers have proposed targeting haplotypes. The larger number of haplotypes, however, relative to alleles at individual loci, could decrease power because of the additional degrees of freedom required for the test. An optimal strategy would focus the test on particular haplotypes or groups of haplotypes, much as is done with cladistic-based association analysis. First suggested by Templeton et al. ([1987] Genetics 117:343-351), such analyses use the evolutionary relationships among haplotypes to produce a limited set of hypothesis tests and to increase the interpretability of these tests. To more fully utilize the information contained in the evolutionary relationships among haplotypes and in the sample, we propose generalized linear models (GLM) for the analysis of data from family-based and population-based studies. These models fully account for haplotype phase ambiguity and allow for covariates. The models are encoded into a software package (the Evolutionary-Based Haplotype Analysis Package, EHAP), which also provides for various kinds of exploratory data analysis. The exploratory analyses, such as error checking, estimation of haplotype frequencies, and tools for building cladograms, should facilitate the implementation of cladistic-based association analysis with haplotypes.

Genetic Predisposition to Disease↗